Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

EGX:PHAR Revenue

Egyptian International Pharmaceutical Industries Company had revenue of 2.52B EGP in the quarter ending June 30, 2026, with 9.09% growth. This brings the company's total for the last twelve months to 9.88B, up 12.08% year-over-year. In the year 2025, Egyptian International Pharmaceutical Industries Company had annual revenue of 9.44B with 24.38% growth. That makes Egyptian International Pharmaceutical Industries Company the 18,153rd largest company in the world by revenue and 48th in Egypt.

• Revenue (ttm): 9.88B
• Revenue Growth: +12.08%
• P/S Ratio: 1.78
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 17.62B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Egypt 6.42B 68.0%
• Export 2.97B 31.4%
• Unallocated 49.37M 0.5%

Fiscal year ended Dec 31, 2025 See the full EGX:PHAR breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.44B	1.85B	24.38%
Dec 31, 2024	7.59B	2.36B	45.09%
Dec 31, 2023	5.23B	1.28B	32.27%
Dec 31, 2022	3.96B	546.35M	16.03%
Dec 31, 2021	3.41B	523.18M	18.13%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error